Two dose regimens of nifedipine for management of preterm labor: A randomized controlled trial

American Journal of Perinatology

Volumn 26, Issue 8, 2009, Pages 575-581

  Nassar, Anwar ^a   Abu Musa, Antoine A ^a   Awwad, Johnny ^a   Khalil, Ali ^a   Tabbara, Jad ^a   Usta, Ihab M ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Nifedipine; Preterm labor; Tocolysis; Two dose regimens

Indexed keywords

NIFEDIPINE;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; BIRTH WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DRUG RELEASE; DRUG WITHDRAWAL; DYSPNEA; FEMALE; FLUSHING; GESTATIONAL AGE; HEADACHE; HEART PALPITATION; HUMAN; HYPOTENSION; LOADING DRUG DOSE; LOW DRUG DOSE; LUNG EDEMA; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; NAUSEA; NEWBORN INTENSIVE CARE; NEWBORN MORBIDITY; PREGNANCY; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TACHYCARDIA; THORAX PAIN; TOCOLYSIS; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADULT; FEMALE; HUMANS; NIFEDIPINE; OBSTETRIC LABOR, PREMATURE; PREGNANCY; TOCOLYTIC AGENTS; UTERINE CONTRACTION;

EID: 70349470925     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0029-1220780     Document Type: Article

References (25)

1. Martin JA, Hamilton BE, Sutton PD, et al. Births: final data for 2005. Natl Vital Stat Rep 2007;56:1-103
2. Lewis DF. Magnesium sulfate: the first-line tocolytic. Obstet Gynecol Clin North Am 2005;32:485-500
3. Crowther CA, Hiller JE, Doyle LW. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database Syst Rev 2002:CD001060
4. (Pubitemid 44277053) Nassar AH, Sakhel K, Maarouf H, Naassan GR, Usta IM. Adverse maternal and neonatal outcome of prolonged course of magnesium sulfate tocolysis. Acta Obstet Gynecol Scand 2006;85:1099-1103
5. (Pubitemid 44498262) Grimes DA, Nanda K. Magnesium sulfate tocolysis: time to quit. Obstet Gynecol 2006;108:986-989
6. (Pubitemid 34665044) Mittendorf R, Dambrosia J, Pryde PG, et al. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. Am J Obstet Gynecol 2002;186:1111-1118
7. Anotayanonth S, Subhedar NV, Garner P, Neilson JP, Harigopal S. Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev 2004:CD004352
8. Papatsonis D, Flenady V, Cole S, Liley H. Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane Database Syst Rev 2005:CD004452
9. King JF, Flenady VJ, Papatsonis DN, Dekker GA, Carbonne B. Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst Rev 2003:CD002255
10. Duley LM. Tocolytic drugs for women in preterm labour. RCOG (Royal College of Obstetricians and Gynaecologists, UK) Guideline No 1B. London: RCOG; 2002
11. (Pubitemid 29503598) Carr DB, Clark AL, Kernek K, Spinnato JA. Maintenance oral nifedipine for preterm labor: a randomized clinical trial. Am J Obstet Gynecol 1999;181:822-827
12. PATH, World Health Organization, United Nations Population Fund. Essential medicines for reproductive health: guiding principles for their inclusion on national medicines lists. Seattle, WA: PATH; 2006. Available at www.who.int/reproductive-health/publications/essential-medicines/ emls-guidingprinciples.pdf
13. (Pubitemid 32406194) Tsatsaris V, Papatsonis D, Goffinet F, Dekker G, Carbonne B. Tocolysis with nifedipine or beta-adrenergic agonists: a meta-analysis. Obstet Gynecol 2001;97:840-847
14. Glock JL, Morales WJ. Efficacy and safety of nifedipine versus magnesium sulfate in the management of preterm labor: a randomized study. Am J Obstet Gynecol 1993;169: 960-964
15. Papatsonis DN, van Geijn HP, Bleker OP, Ader HJ, Dekker GA. Hemodynamic and metabolic effects after nifedipine and ritodrine tocolysis. Int J Gynaecol Obstet 2003;82: 5-10
16. van Veen AJ, Pelinck MJ, van Pampus MG, Erwich JJ. Severe hypotension and fet al. death due to tocolysis with nifedipine. BJOG 2005;112:509-510
17. (Pubitemid 20024015) Ferguson JE 2nd, Schutz T, Pershe R, Stevenson DK, Blaschke T. Nifedipine pharmacokinetics during preterm labor tocolysis. Am J Obstet Gynecol 1989;161:1485-1490
18. Guclu S, Saygili U, Dogan E, Demir N, Baschat AA. The short-term effect of nifedipine tocolysis on placental, fet al. cerebral and atrioventricular Doppler waveforms. Ultrasound Obstet Gynecol 2004;24:761-765
19. Economy KE, Abuhamad AZ. Calcium channel blockers as tocolytics. Semin Perinatol 2001;25:264-271
20. (Pubitemid 40313988) van Geijn HP, Lenglet JE, Bolte AC. Nifedipine trials: effectiveness and safety aspects. BJOG 2005;112:79-83
21. Nassar AH, Ghazeeri G, Usta IM. Nifedipine-associated pulmonary complications in pregnancy. Int J Gynaecol Obstet 2007;97:148-149
22. Verhaert D, Van Acker R. Acute myocardial infarction during pregnancy. Acta Cardiol 2004;59:331-339
23. (Pubitemid 43961749) Parasuraman R, Gandhi MM, Liversedge NH. Nifedipine tocolysis associated atrial fibrillation responds to DC cardioversion. BJOG 2006;113:844-845
24. (Pubitemid 46089459) Ugwumadu A. Nifedipine-tocolysis-associated atrial fibrillation responds to DC cardioversion. BJOG 2007;114:236- 237
25. Taslimi MM, Sibai BM, Amon E, Taslimi CK, Herrick CN. A national survey on preterm labor. Am J Obstet Gynecol 1989;160:1352-1357